Evolution in Clinical Trial Design: Measuring PAH Treatment Efficacy

preview_player
Показать описание
Charles Burger, MD, discusses the challenges of evaluating treatments for pulmonary arterial hypertension and the evolution of clinical trial design from surrogate end points to ones that are more outcomes-based.
Рекомендации по теме